Literature DB >> 19162439

Encopresis, soiling and constipation in children and adults with developmental disability.

Johnny L Matson1, Santino V LoVullo.   

Abstract

Children and adults with developmental disabilities are more likely to evince encopresis, soiling and constipation than the general population. This set of related behaviors can produce a great deal of stress and can be a major restriction in independent living. This paper provides a review of the current state of knowledge on the prevalence, etiology, assessment and treatment of this co-occurring set of disorders. These problems are more common in persons with developmental disabilities then the general population. Furthermore, classical and operant treatment methods appear to be the best supported interventions for most cases. Strengths and weaknesses of the current research base are discussed along with potential avenues for future research.

Entities:  

Mesh:

Year:  2009        PMID: 19162439     DOI: 10.1016/j.ridd.2008.12.001

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  3 in total

1.  A Pilot Randomized Clinical Trial of a Multidisciplinary Intervention for Encopresis in Children with Autism Spectrum Disorder.

Authors:  Joanna Lomas Mevers; Nathan A Call; Kristina R Gerencser; Mindy Scheithauer; Sarah J Miller; Colin Muething; Shannon Hewett; Courtney McCracken; Lawrence Scahill; Barbara O McElhanon
Journal:  J Autism Dev Disord       Date:  2020-03

2.  Found in feces: differential diagnosis, workup, and treatment.

Authors:  Theodore A Stern; J Carl Pallais; Jeremiah M Scharf; Steven C Schlozman
Journal:  Prim Care Companion CNS Disord       Date:  2012-06-21

3.  Psychomotor approach in children affected by nonretentive fecal soiling (FNRFS): a new rehabilitative purpose.

Authors:  Maria Esposito; Francesca Gimigliano; Maria Ruberto; Rosa Marotta; Beatrice Gallai; Lucia Parisi; Serena Marianna Lavano; Giovanni Mazzotta; Michele Roccella; Marco Carotenuto
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-19       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.